Relationship between brain-derived neurotrophic factor and schneiderian first rank symptoms in antipsychotic-naïve schizophrenia

Frontiers in Psychiatry

Volumn 4, Issue JUL, 2013, Pages

  Kalmady, Sunil Vasu ^a   Venkatasubramanian, Ganesan ^a   Shivakumar, Venkataram ^a   Jose, Dania ^a   Ravi, Vasanthapuram ^a   Gangadhar, Bangalore N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Antipsychotic na ve BDNF; Schizophrenia; Schneiderian first rank symptoms

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROLEPTIC AGENT;

ADULT; AGE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SCHNEIDERIAN FIRST RANK SYMPTOM; SYMPTOMATOLOGY;

EID: 84884584724     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2013.00064     Document Type: Article

References (32)

1. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry (2005) 10:434-49. doi:10.1038/sj.mp.4001642
2. Nicodemus KK, Marenco S, Batten AJ, Vakkalanka R, Egan MF, Straub RE, et al. Serious obstetric complications interact with hypoxia-regulated/vascularexpression genes to influence schizophrenia risk. Mol Psychiatry (2008) 13:873-7. doi:10.1038/sj.mp.4002153
3. Bellon A, Krebs MO, Jay TM. Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia. Prog Neurobiol (2011) 94:77-90. doi:10.1016/j.pneurobio.2011.04.003
4. Buckley PF, Pillai A, Howell KR. Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry (2011) 24:122-7. doi:10.1097/YCO.0b013e3283436eb7
5. Favalli G, Li J, Belmonte-De-Abreu P, Wong AH, Daskalakis ZJ. The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res (2012) 46:1-11. doi:10.1016/j.jpsychires.2011.09.022
6. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci (2004) 24:10099-102. doi:10.1523/JNEUROSCI.2680-04.2004
7. Shoval G, Weizman A. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol (2005) 15:319-29. doi:10.1016/j.euroneuro.2004.12.005
8. Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN, et al. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci (2005) 25:372-83. doi:10.1523/JNEUROSCI.4035-04.2005
9. Issa G, Wilson C, Terry AV Jr., Pillai A. An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiol Dis (2010) 39:327-33. doi:10.1016/j.nbd.2010.04.017
10. Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H, et al. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol (2010) 13:535-9. doi:10.1017/S1461145709991015
11. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol (2011) 14:347-53. doi:10.1017/S1461145710000738
12. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry (2010) 16:960-72. doi:10.1038/mp.2010.88
13. Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S. Brain derived neurotropic factor in first-episode psychosis. Schizophr Res (2007) 91:1-5. doi:10.1016/j.schres.2006.12.026
14. Bhang S, Ahn JH, Choi SW. Brain-derived neurotrophic factor and serotonin transporter gene-linked promoter region genes alter serum levels of brain-derived neurotrophic factor in humans. J Affect Disord (2011) 128:299-304. doi:10.1016/j.jad.2010.07.008
15. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry (2006) 59:812-5. doi:10.1016/j.biopsych.2005.09.022
16. Gruber O, Hasan A, Scherk H, Wobrock T, Schneider-Axmann T, Ekawardhani S, et al. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system. Eur Arch Psychiatry Clin Neurosci (2012) 262:23-31. doi:10.1007/s00406-011-0214-6
17. Eker C, Kitis O, Ozan E, Okur H, Eker OD, Ersoy MA, et al. BDNF gene Val66met polymorphism associated grey matter changes in human brain. Klin Psikofarmakol Bül (2005) 15:104-11.
18. Jardri R, Pouchet A, Pins D, Thomas P. Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis. Am J Psychiatry (2011) 168:73-81. doi:10.1176/appi.ajp.2010.09101522
19. Spence SA, Brooks DJ, Hirsch SR, Liddle PF, Meehan J, Grasby PM. A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). Brain (1997) 120(Pt 11):1997-2011. doi:10.1093/brain/120.11.1997
20. Franck N, O'Leary DS, Flaum M, Hichwa RD, Andreasen NC. Cerebral blood flow changes associated with Schneiderian first-rank symptoms in schizophrenia. J Neuropsychiatry Clin Neurosci (2002) 14:277-82. doi:10.1176/appi.neuropsych.14.3.277
21. Ganesan V, Hunter MD, Spence SA. Schneiderian first-rank symptoms and right parietal hyperactivation: a replication using FMRI. Am J Psychiatry (2005) 162:1545. doi:10.1176/appi.ajp.162.8.1545
22. Venkatasubramanian G, Jayakumar PN, Keshavan MS, Gangadhar BN. Schneiderian first rank symptoms and inferior parietal lobule cortical thickness in antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2011) 35:40-6. doi:10.1016/j.pnpbp.2010.07.023
23. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 59(Suppl 20):22-33. quiz 34-57,
24. Mellor CS. First rank symptoms of schizophrenia. I. The frequency in schizophrenics on admission to hospital. II. Differences between individual first rank symptoms. Br J Psychiatry (1970) 117:15-23.
25. Rizos EN, Rontos I, Laskos E, Arsenis G, Michalopoulou PG, Vasilopoulos D, et al. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 32:1308-11. doi:10.1016/j.pnpbp.2008.04.007
26. Chen Da C, Wang J, Wang B, Yang SC, Zhang CX, Zheng YL, et al. Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl) (2009) 207:375-80. doi:10.1007/s00213-009-1665-6
27. Jindal RD, Pillai AK, Mahadik SP, Eklund K, Montrose DM, Keshavan MS. Decreased BDNF in patients with antipsychotic naive first episode schizophrenia. Schizophr Res (2010) 119:47-51. doi:10.1016/j.schres.2009.12.035
28. Suzuki M, Zhou SY, Hagino H, Niu L, Takahashi T, Kawasaki Y, et al. Morphological brain changes associated with Schneider's first-rank symptoms in schizophrenia: a MRI study. Psychol Med (2005) 35:549-60. doi:10.1017/S0033291704003885
29. Montag C, Weber B, Fliessbach K, Elger C, Reuter M. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychol Med (2009) 39:1831-9. doi:10.1017/S0033291709005509
30. Chiang MC, Avedissian C, Barysheva M, Toga AW, Mcmahon KL, De Zubicaray GI, et al. Extending genetic linkage analysis to diffusion tensor images to map single gene effects on brain fiber architecture. Med Image Comput Comput Assist Interv (2009) 12:506-13.
31. Ozan E, Okur H, Eker C, Eker OD, Gonul AS, Akarsu N. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull (2010) 81:61-5. doi:10.1016/j.brainresbull.2009.06.022
32. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology (1998) 37:1553-61. doi:10.1016/S0028-3908(98)00141-5